Glutathione S-transferases μ1, &thgr;1, π1, α1 and μ3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans

By Martínez Carmen   Martín Felipe   Fernández Juana M   García-Martín Elena   Sastre Javier   Díaz-Rubio Manuel   Agúndez José AG   Ladero José M  

Pharmacogenomics, Vol. 7, Iss. 5, 2006-07 ,pp. : 711-718

Future Medicine

Access to resources Recommend Favorite

MACC1 - a novel target for solid cancers

By Stein Ulrike  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 9, 2013-09 ,pp. : 1039-1052

Informa Healthcare

Access to resources Recommend Favorite

EGFR(S) Inhibitors in the Treatment of Gastro-Intestinal Cancers: What's New?

By  

Current Drug Targets, Vol. 11, Iss. 6, 2010-06 ,pp. : 682-698

Bentham Science Publishers

Access to resources Recommend Favorite

CYP2E1 and risk of chemically mediated cancers

By Trafalis Dimitrios T   Panteli Eleftheria S   Grivas Anastasios   Tsigris Christos   Karamanakos Petros N  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 307-319

Informa Healthcare

Access to resources Recommend Favorite

Niacin/simvastatin a practical combo in dyslipidaemia

By  

Inpharma, Vol. 1, Iss. 1637, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite